masimo

If you own an Apple Watch, you may have noticed the device’s pulse oximeter feature. Masimo, a medical technology company, claims that the oximeter technology is theirs and it is suing Apple. Masimo CEO Joe Kiani and WSJ’s Aaron Tilley on the story of how Masimo decided to take on a tech giant.  Further Listening: -One Company’s Quest to Burst Apple’s Blue Bubble Texts  Further Reading: -The Entrepreneur Who Bet His Company on a Fight With Apple  -Apple to Remove Blood-Oxygen Sensor From Watch to Avoid U.S. Ban  Learn more about your ad choices. Visit megaphone.fm/adchoices

Institutional investors make headlines with sweeping predictions about the economy, but there’s not much of a consequence if they’re wrong. (00:21) Ricky Mulvey and Jason Moser discuss:  - Apple resuming watch sales, and long battle against Masimo.  - Why it’s difficult to make accurate economic predictions.  - Understanding a business’s valuation and its story.  - A stock and an ETF we plan on holding through 2024. Plus, (17:42) Robert Brokamp and Alison Southwick provide some tips to be more productive in the new year. Stocks/ETFs mentioned: AAPL, MASI, TDOC, AXON, SCHD Link to receive a complimentary report on dividend stocks: www.fool.com/2024dividends Learn more about your ad choices at megaphone.fm/adchoices Hosts: Ricky Mulvey Guests: Jason Moser, Alison Southwick, Robert Brokamp Producer: Mary Long Engineers: Dan Boyd, Rick Engdahl Learn more about your ad choices. Visit megaphone.fm/adchoices